Mohammadzadeh, A and Pourfathollah, A.A and Shahrokhi, S and Fallah, A and Tahoori, M.T and Amari, A and Forouzandeh, M and Soleimani, M (2016) Evaluation of AD-MSC (adipose-derived mesenchymal stem cells) as a vehicle for IFN-β delivery in experimental autoimmune encephalomyelitis. Clinical Immunology, 169. pp. 98-106.
|
Text
1-s2.0-S1521661616301383-main.pdf Download (1MB) | Preview |
Abstract
Interferon-β (IFN-β) is commonly used as a disease modifying drug for the treatment of relapse-remitting multiple sclerosis (RR-MS). However, the underlyingmechanismbywhich IFN-β mediate this immunosuppressive effect is still unknown. In this study, we analyzed the effects of genetically modified adipose-derived mesenchymal stem cells (AD-MSCs) expressing murine interferon beta (MSCs-VP/IFN-β) on the animal model ofMS, experimental autoimmune encephalomyelitis (EAE). Lymph node mononuclear cells and serum were examined by using RT-PCR and ELISA methods tomeasure the production of IL-10 and IL-17 gene and protein expression, respectively. Our results indicated that in the MSCs-VP/IFN-β treated group induction of Tregs and IL-10 and reduction of IL-17 were significant. Taken together, we showed that using AD-MSCs expressing IFN-β as an anti-inflammatory agent, offer evidence supporting that the stem cell therapies in EAE conceivably will improve the valuable effects of IFN-β in this autoimmune disease
| Item Type: | Article |
|---|---|
| Additional Information: | cited By 0 |
| Uncontrolled Keywords: | MSCs (mesenchymal stem cells) IFN-β Treg EAE |
| Subjects: | R Medicine > R Medicine (General) |
| Depositing User: | Unnamed user with email gholipour.s@umsu.ac.ir |
| Date Deposited: | 18 Jul 2017 04:47 |
| Last Modified: | 13 Feb 2019 05:35 |
| URI: | http://eprints.umsu.ac.ir/id/eprint/205 |
Actions (login required)
 |
View Item |
